Background: Narrow-band UVB (NB-UVB) has been shown to be one of the most effective treatment modalities for psoriasis. Tazarotene, a known effective anti-psoriatic modality, when combined with NB-UVB may enhance the therapeutic success.
Objective: To study clinical efficacy and safety of combination of NB-UVB with topical tazarotene 0.